Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways

Background/Aim: Oral squamous cell carcinoma (OSCC) has limited treatment options. This study investigated imipramine, a tricyclic antidepressant, as a potential therapy for OSCC using a SAS-bearing xenograft animal model. Materials and Methods: The SAS-bearing xenograft model evaluated imipramine’s impact on tumor growth. The control group received no treatment, while the imipramine-treated group received regular doses. Tumor growth, confirmed by imaging, and histological analysis assessed size and weight. Imipramine’s effects on apoptosis, epithelial-to-mesenchymal transition (EMT), and transcription factors (AKT, ERK, STAT3) were analyzed. Results: Imipramine significantly suppressed tumor growth within 6 days of treatment, with sustained activity. Computer tomography (CT) scans and histology confirmed reduced size and weight by imipramine. Imipramine induced apoptosis via caspase-dependent/-independent pathways, inhibited EMT, and down-regulated phosphorylated AKT, ERK, and STAT3. Conclusion: Imipramine shows promise as an effective OSCC therapy, inhibiting tumor growth, inducing apoptosis, and inhibiting EMT. Its impact on transcription factors and modulation of the AKT/ERK/STAT3 pathway suggest a multifaceted approach.

[1]  Fei-Ting Hsu,et al.  Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  M. Hotopf,et al.  Antidepressants for the treatment of depression in people with cancer. , 2023, The Cochrane database of systematic reviews.

[3]  C. Yeh,et al.  Anticancer Effects of Antidepressants in Hepatocellular Carcinoma Cells , 2023, AntiCancer Research.

[4]  X. Chang,et al.  The application of antidepressant drugs in cancer treatment. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  M. Hashemi,et al.  EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  T. Hsia,et al.  Allyl Isothiocyanate (AITC) Induces Apoptotic Cell Death In Vitro and Exhibits Anti-Tumor Activity in a Human Glioblastoma GBM8401/luc2 Model , 2022, International journal of molecular sciences.

[7]  H. Kao,et al.  The impact of depression on survival of head and neck cancer patients: A population-based cohort study , 2022, Frontiers in Oncology.

[8]  Fei-Ting Hsu,et al.  STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo , 2022, AntiCancer Research.

[9]  Yifan Ren,et al.  LOXL3‐promoted hepatocellular carcinoma progression via promotion of Snail1/USP4‐mediated epithelial‐mesenchymal transition , 2022, Environmental toxicology.

[10]  S. Hindy.  Significance and expression of p-Akt in oral squamous cell carcinoma , 2022, Journal of oral and maxillofacial pathology : JOMFP.

[11]  Chi-Hsiang Chung,et al.  Risk of depression in patients with oral cancer: a nationwide cohort study in Taiwan , 2021, Scientific Reports.

[12]  Fei-Ting Hsu,et al.  Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer , 2021, Frontiers in Oncology.

[13]  M. Ashrafizadeh,et al.  Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  V. B.,et al.  Cervical lymph node metastasis in squamous cell carcinoma of the buccal mucosa: a retrospective study on pattern of involvement and clinical analysis. , 2020, Medicina oral, patologia oral y cirugia bucal.

[15]  L. Ye,et al.  miR‐146a promotes proliferation, invasion, and epithelial‐to‐mesenchymal transition in oral squamous carcinoma cells , 2020, Environmental toxicology.

[16]  I. Farooq,et al.  Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis , 2020, F1000Research.

[17]  Fei-Ting Hsu,et al.  Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF‐κB signalling participate in anti‐glioblastoma of imipramine , 2020, Journal of cellular and molecular medicine.

[18]  B. Wollenberg,et al.  Immunohistochemical Analysis of Transcription Factors and Markers of Epithelial–Mesenchymal Transition (EMT) in Human Tumors , 2019, AntiCancer Research.

[19]  Jing-Gung Chung,et al.  Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Amareshwar T. K. Singh,et al.  Apoptosis: A Target for Anticancer Therapy , 2018, International journal of molecular sciences.

[21]  Y. Ko,et al.  Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies , 2016, Oncotarget.

[22]  Fei-Ting Hsu,et al.  Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo , 2015, Scientific Reports.

[23]  T. Sio,et al.  Doxepin for Radiation Therapy-Induced Mucositis Pain in the Treatment of Oral Cancers , 2015, Oncology reviews.

[24]  G. Rassidakis,et al.  Erk1/2 activation and modulation of STAT3 signaling in oral cancer. , 2014, Oncology reports.

[25]  Fei-Ting Hsu,et al.  Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells. , 2014, In vivo.

[26]  H. Sayles,et al.  Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. , 2013, JAMA otolaryngology-- head & neck surgery.

[27]  Xiaomin Su,et al.  Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. , 2011, International journal of radiation oncology, biology, physics.

[28]  S. Shukla,et al.  Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival. , 2006, The International journal of biological markers.

[29]  Yen-Chung Chen,et al.  Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells. , 2017, Anticancer research.

[30]  M. Millan,et al.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs , 2011, Neurotherapeutics.

[31]  J. Klijanienko,et al.  Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival , 2014, Tumor Biology.